Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - LONG-TERM DEBT
Long-term Debt ALNY - Alnylam Pharmaceuticals, Inc.
2.59 B
LAST VALUE
10.76%
2 YEAR CAGR
143.84%
5 YEAR CAGR
0.00%
10 YEAR CAGR